Paul Kay, Partner
Paul advises clients on all forms of debt and equity financing, structured finance, asset-based lending, securitisations and property finance.
SummaryPaul is Head of the Banking and Finance group. His specialism includes all forms of debt and equity financing, structured finance, asset-based lending, securitisations and property finance. He advises lenders, borrowers, issuers and investment managers on a range of transactions and undertakes transactions in a wide range of property, financial and service sectors. He has significant experience in cross-border and international transactions. He has acted on many real estate financings in the UK, acting for the UK clearing and international financing banks and for borrowers.
Paul qualified as a barrister in Chancery and Tax chambers before joining Charles Russell Speechlys LLP. He formerly lectured, part-time (evening), at London University for its external LLB. He has published a variety of articles in legal journals and lectured at a number of academic and professional seminars. He undertakes transactions in a wide range of property, financial and service sectors, and has significant experience in cross-border and international transactions.
Paul is admitted to practise in England and Wales.
- Advising on the £300m syndicated loan facilities provided to a leading Healthcare investment fund by Lloyds Banking Group
- Advising on the financing of a leading geothermal energy provider in a pre-securitisation institutionally credit enhanced investment structure financed by Macquarie Bank
- Advising on a US$250m margin call facility for investment in shares in a leading listed natural resources group
- Advising private investment offices on pre-export financing facilities and private equity capital call investment facilities
News & Insights
Charles Russell Speechlys advises fastjet on placing, subscription, open offer & balance sheet restructuring
Charles Russell Speechlys advise fastjet plc, on its placing, subscription, open offer and balance sheet restructuring to issue equity
Charles Russell Speechlys advises Kreos Capital on €20 million growth capital facility in Medtech company
Charles Russell Speechlys have advised Kreos Capital on its additional growth capital facility of €20 million in Cellnovo Limited